Calidi Biotherapeutics (CLDI) Precio de Acción, Cotización, Noticias e Historial | Benzinga

Calidi Biotherapeutics Inc (CLDI) Precio de Acción, Cotización, Noticias e Historial

CLDIAMEX

Trade with Public

Trade with Public

$0.7834

-0.0536-6.4%

Últ. Act.: Oct 19, 6:30 PM

Panorámica generalNoticias Previsión de beneficios Eventos Precios objetivo Finanzas Sentimiento Propiedad Comparar Informe de acciones

© 2026 Benzinga | All Rights Reserved

Estadísticas Clave

Apertura

$0.80

Cierre

$0.78

Volumen / Prom.

54.81K / 248.57K

Rango diario

$0.75 - $0.83

Rango de 52 semanas

0.82 - 27.84

Capitalización bursátil

$2.02M

Ratio PER

-

Rentabilidad por dividendo

-

Exchange

AMEX

RSI

23

Interés en corto

9.1%

Días para cubrir

1

Noticias Recientes de Calidi Biotherapeutics Inc

Why Crown Holdings Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Crown Holdings Inc (CCK) stock gained 16.4% in pre-market trading after reporting strong Q2 results and raising its FY26 EPS guidance. Other gaining stocks include SLGB, HIHO, WNW, CHNR, RDGT, ULBI, GLMD, SMTK, and PRTA while LBGJ is down 45.1%.

Avi Kapoor

Why Bed Bath & Beyond Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket

Shares of Bed Bath & Beyond (BBBY) rose 23.4% in pre-market trading after beating revenue estimates. KIDZ, CLDI, DRCT, PFSA, KFRC, MLEC, SANM, SEI, DT are also up while VISN, ERAS, AREB, and YAAS are down.

Avi Kapoor

Crude Oil Jumps Over 12%; US Retail Sales Fall In January

U.S. stocks fall on Friday with the S&P 500 and NASDAQ dropping around 1%. Energy shares rise while financial stocks dip. Retail sales decline and job growth slows in February.

Avi Kapoor

Nasdaq Down Over 300 Points; US Economy Loses 92,000 Jobs In February

Stocks down, Nasdaq falls 300+ points. Dow down 1.62%, Nasdaq down 1.47%, S&P 500 down 1.38%. Energy shares rise, financial stocks dip. US economy loses 92K nonfarm payrolls in Feb.

Avi Kapoor

Calidi Biotherapeutics (CLDI) Stock Plunges 35% After Hours — Here's Why

Calidi Biotherapeutics shares plunged after hours following a public offering announcement, trading near their 52-week low.

Mohd Haider

Finanzas

Trimestral

Anual

Nombre

Ingresos Variación
Bruto Variación
EBITDA Variación
EBIT Variación
Beneficios Variación

Flujos de Caja

Flujo de Caja Operativo (TTM)

-17.75M

Flujo de Caja de Inversión (TTM)

-144.00K

Flujo de Caja de Financiación (TTM)

16.81M

Flujo de Caja Libre (TTM)

-17.85M

Gasto de Capital (TTM)

-94.00K

Cambio Neto en Efectivo (TTM)

-1.09M

Calificación de analistas

4.2

Compra

Compra fuerte

Compra

Mantener

Venta

Venta fuerte

Métricas de Valoración

Valor Empresarial

$33.96K

Relación P/E (TTM)

-

Relación P/E (FWD)

-

Relación PEG (TTM)

-

Relación P/S (TTM)

-

Relación P/B (TTM)

0.69

Rendimiento de Ganancias % (TTM)

-4425.33%

Rendimiento de Ganancias % (FWD)

-

EV / EBITDA (TTM)

-

Precio / EBITDA (TTM)

-

Precio / Flujo de Caja Libre (TTM)

-

Valor Contable / Acción

$1.21

Deuda Empresarial

Deuda Total

$600.00K

Deuda a Largo Plazo

$600.00K

Emisión de Deuda a Largo Plazo (TTM)

-

Reembolso de Deuda a Largo Plazo (TTM)

-$522.00K

Efectivo Total

$4.07M

Deuda a Capital

0.62

Emisión de Deuda (TTM)

-$522.00K

Reembolso de Deuda (TTM)

-$522.00K